BridgeBio Pharma BBIO SEC Filings

NASDAQ BBIO
$74.41 -1.00 (-1.33%)
As of: Sep 4, 2026 · 11:50 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document BridgeBio Pharma, Inc. (BBIO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index